Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
Vincent Soriano(Fundación Instituto Valenciano de Oncología), Jürgen Rockstroh(University of Bonn), Douglas T. Dieterich(Icahn School of Medicine at Mount Sinai), Stefan Mauss(Center for HIV and Hepatogastroenterology), P. Cacoub(Sorbonne Université), Thierry Poynard(Centre National de la Recherche Scientifique), Carlo Ferrari(University of Parma), Colm Bergin, Santiago Moreno(Universidad El Bosque), Angelos Hatzakis(National and Kapodistrian University of Athens), Antonietta Cargnel(Luigi Sacco Hospital), Mark Sulkowski(Johns Hopkins University), Christine Katlama(Université Paris Cité)
Cited by 443
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
|Hepatology|1996|678
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653